Buda Juice Inc

Buda Juice Inc(BUDA)股票分析

$6.550

-0.069 (-1.06%)收盤時

Loading chart…
最高
7.115
開盤
7.115
成交量加權均價
6.65
成交量
5.98K
市值
—
最低
6.300
成交金額
39.81K
企業價值/稅息折舊攤銷前利潤(TTM)
27.16

Buda Juice, Inc. operates in a beverage industry, focused on UltraFresh juice-offering cold-crafted citrus-based drinks. The Company offers an end-to-end cold chain platform that always delivers cold, freshly crafted juice, lemonades and wellness shots to grocery retailers in Texas. Its product portfolio consists of fresh citrus juice, a fresh citrus-based line of lemonades and wellness shot offerings across multiple brand lines and retail customers, all produced using its cold chain process. Its products include Buda Juice (Organic), Buda Fresh - Value-Forward Offering (Non-Organic), and Private Label Products (Non-organic and Organic). Buda Fresh includes Fresh 12 oz Lime Juice, 16 oz and 128 oz Lemon Juice, Fresh Orange and Grapefruit Juice (16 oz, 32 oz and 52 oz), and Fresh Citrus-based Lemonades and Limeades (16 oz and 52 oz). Private Label Products include Fresh Citrus Line (52 oz) and Fresh Citrus-based Lemonades and Limeades (52 oz).

AI 分析 of Buda Juice Inc (BUDA)

買進

Buda Juice appears to be a strong buy at the current price of $7.22, especially with an RSI of 62.22 indicating bullish momentum. The stock has a significant upside potential with an analyst price target of $12, suggesting a potential gain of 66.67%. Additionally, the company has shown robust revenue growth, with Q2 2026 revenue reaching $4.5 million, a substantial increase compared to previous quarters. However, investors should be cautious of the forward P/E ratio of 49.02, which indicates that the stock may be overvalued if growth does not meet expectations.

估值指標

Buda Juice Inc(BUDA)目前預期本益比為 49.26,5 年平均預期本益比為 48.93。

預期本益比

合理
5 年均值 P/E
48.93
目前P/E
49.26
高估
50.18
低估
47.68

預期 EV/EBITDA

合理
5 年均值 EV/EBITDA
49.93
目前EV/EBITDA
27.16
高估
179.76
低估
-79.90

預期股價營收比

合理
5 年均值 P/S
170.84
目前P/S
4.00
高估
1138.27
低估
-796.59

事件時間軸

2026-08-13 (ET)

07:30:00

Buda Juice Reports Q2 Revenue of $4.5M

2026-05-26 (ET)

07:10:00

Buda Juice Dual Lists on NYSE Texas Effective May 26, 2026

2026-05-13 (ET)

07:10:00

Buda Juice Reports Q1 Adjusted EPS of 5 Cents, Revenue of $3.5M

2026-05-11 (ET)

07:00:00

Buda Juice Launches New Drink in 246 Walmart Stores

2026-03-26 (ET)

07:10:00

Buda Juice Reports FY25 Revenue of $12.6M

資訊

BUDA 常見問題 —— 由 Alphio AI 解答

Buda Juice, Inc. operates in a beverage industry, focused on UltraFresh juice-offering cold-crafted citrus-based drinks. The Company offers an end-to-end cold chain platform that always delivers cold, freshly crafted juice, lemonades and wellness shots to grocery retailers in Texas. Its product portfolio consists of fresh citrus juice, a fresh citrus-based line of lemonades and wellness shot offerings across multiple brand lines and retail customers, all produced using its cold chain process. Its products include Buda Juice (Organic), Buda Fresh - Value-Forward Offering (Non-Organic), and Private Label Products (Non-organic and Organic). Buda Fresh includes Fresh 12 oz Lime Juice, 16 oz and 128 oz Lemon Juice, Fresh Orange and Grapefruit Juice (16 oz, 32 oz and 52 oz), and Fresh Citrus-based Lemonades and Limeades (16 oz and 52 oz). Private Label Products include Fresh Citrus Line (52 oz) and Fresh Citrus-based Lemonades and Limeades (52 oz). It operates in the Consumer Non-Cyclicals sector.

Buda Juice appears to be a strong buy at the current price of $7.22, especially with an RSI of 62.22 indicating bullish momentum. The stock has a significant upside potential with an analyst price target of $12, suggesting a potential gain of 66.67%. Additionally, the company has shown robust revenue growth, with Q2 2026 revenue reaching $4.5 million, a substantial increase compared to previous quarters. However, investors should be cautious of the forward P/E ratio of 49.02, which indicates that the stock may be overvalued if growth does not meet expectations.

暫無貼文

註冊或登入後參與討論

相關文章

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

開始交易